Boston Scientific Corp (BSX) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, Boston Scientific reported revenue of $20.07B, up 19.9% from $16.75B the year before. Net income was $2.90B (a 14.4% net margin), or $1.94 per diluted share. Gross margin was 69.0% and operating margin was 18.0%. Operating activities generated $4.53B of cash, leaving $3.66B of free cash flow. At fiscal year end, Boston Scientific held $43.67B in total assets against $19.44B in total liabilities, including $1.97B of cash and equivalents.
Open the full interactive Boston Scientific financials → Quarterly statements, key ratios, valuation history and price charts.
Boston Scientific Key Stats
| Share Price | $43.31 |
|---|---|
| Market Cap | $63.87B |
| P/E Ratio | 22.3 |
| Revenue YoY Growth | +19.9% |
| 52-Week Range | $41.58 – $104.98 |
| Shares Outstanding | 1.47 billion (basic, 2026 Q2) |
Boston Scientific Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $9.91B | $11.89B | $12.68B | $14.24B | $16.75B | $20.07B |
| Cost of Goods Sold | $3.46B | $3.71B | $3.96B | $4.34B | $5.26B | $6.22B |
| Gross Profit | $6.45B | $8.18B | $8.73B | $9.90B | $11.49B | $13.85B |
| Operating Income | -$80.0M | $1.20B | $1.65B | $2.34B | $2.60B | $3.61B |
| Pre-Tax Income | -$79.0M | $1.08B | $1.14B | $1.99B | $2.28B | $3.38B |
| Income Tax | $2.0M | $36.0M | $443.0M | $393.0M | $436.0M | $493.0M |
| Net Income | -$82.0M | $1.04B | $698.0M | $1.59B | $1.85B | $2.90B |
| Diluted EPS | -$0.08 | $0.69 | $0.45 | $1.07 | $1.25 | $1.94 |
Boston Scientific Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $5.07B | $5.29B | $5.20B | $5.44B |
| Net Income | $755.0M | $672.0M | $1.34B | $907.0M |
| Diluted EPS | $0.51 | $0.45 | $0.90 | $0.61 |
Boston Scientific Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.73B | $1.93B | $928.0M | $865.0M | $414.0M | $1.97B |
| Current Assets | $6.69B | $6.32B | $5.76B | $6.51B | $6.92B | $8.79B |
| Total Assets | $30.78B | $32.23B | $32.47B | $35.14B | $39.40B | $43.67B |
| Current Liabilities | $3.68B | $4.27B | $3.80B | $4.93B | $6.40B | $5.44B |
| Total Long-Term Debt | $9.13B | $8.80B | $8.91B | $8.57B | $8.97B | $11.14B |
| Total Liabilities | $15.45B | $15.61B | $14.90B | $15.85B | $17.62B | $19.44B |
| Shareholders' Equity | $15.33B | $16.62B | $17.57B | $19.28B | $21.77B | $24.23B |
Boston Scientific Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $1.51B | $1.87B | $1.53B | $2.50B | $3.44B | $4.53B |
| Cash From Investing | -$411.0M | -$1.60B | -$2.01B | -$2.57B | -$5.69B | -$2.64B |
| Cash From Financing | $293.0M | -$95.0M | -$548.0M | $5.0M | $1.81B | -$395.0M |
| Free Cash Flow | $1.13B | $1.32B | $938.0M | $1.79B | $2.65B | $3.66B |
| Dividends Paid | $28.0M | $55.0M | $55.0M | $28.0M | $0 | — |
Figures from Boston Scientific's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Boston Scientific financials page for every line item.
Boston Scientific Company Profile
| Ticker | BSX |
|---|---|
| Exchange | NYSE |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Marlborough, Massachusetts |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0000885725 |
Frequently Asked Questions
What was Boston Scientific's revenue in fiscal 2025?
Boston Scientific (BSX) reported revenue of $20.07B for fiscal 2025.
What is Boston Scientific's annual revenue history?
Boston Scientific's annual revenue by fiscal year: 2020: $9.91B; 2021: $11.89B; 2022: $12.68B; 2023: $14.24B; 2024: $16.75B; 2025: $20.07B.
What was Boston Scientific's net income in fiscal 2025?
Boston Scientific reported net income of $2.90B for fiscal 2025.
What was Boston Scientific's earnings per share (EPS) in fiscal 2025?
Boston Scientific's diluted EPS was $1.94 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Boston Scientific generate in fiscal 2025?
Boston Scientific generated $3.66B of free cash flow in fiscal 2025.
What was Boston Scientific's revenue last quarter?
In its most recent reported quarter (2026 Q2), Boston Scientific reported revenue of $5.44B.
How much debt does Boston Scientific have?
Boston Scientific reported $11.14B of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Boston Scientific are outstanding?
Boston Scientific reported a weighted average of 1.47 billion basic shares outstanding in 2026 Q2.
What is Boston Scientific's market cap?
Based on its latest closing price, Boston Scientific (BSX) has a market capitalization of about $63.87B.
When does Boston Scientific's fiscal year end?
Boston Scientific's fiscal year end, as registered with the SEC, is December 31.
Where is Boston Scientific headquartered?
Boston Scientific lists its business address in Marlborough, Massachusetts in its SEC filings.